Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas S. Geraci is active.

Publication


Featured researches published by Nicholas S. Geraci.


BMC Immunology | 2008

Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis

Yi Wen Chen; Rongye Shi; Nicholas S. Geraci; Sheela Shrestha; Heather Gordish-Dressman; Lauren M. Pachman

BackgroundTo evaluate the impact of the duration of chronic inflammation on gene expression in skeletal muscle biopsies (MBx) from untreated children with juvenile dermatomyositis (JDM) and identify genes and biological processes associated with the disease progression, expression profiling data from 16 girls with active symptoms of JDM greater than or equal to 2 months were compared with 3 girls with active symptoms less than 2 months.ResultsSeventy-nine genes were differentially expressed between the groups with long or short duration of untreated disease. Genes involved in immune responses and vasculature remodelling were expressed at a higher level in muscle biopsies from children with greater or equal to 2 months of symptoms, while genes involved in stress responses and protein turnover were expressed at a lower level. Among the 79 genes, expression of 9 genes showed a significant linear regression relationship with the duration of untreated disease. Five differentially expressed genes – HLA-DQA1, smooth muscle myosin heavy chain, clusterin, plexin D1 and tenomodulin – were verified by quantitative RT-PCR. The chronic inflammation of longer disease duration was also associated with increased DC-LAMP+ and BDCA2+ mature dendritic cells, identified by immunohistochemistry.ConclusionWe conclude that chronic inflammation alters the gene expression patterns in muscle of untreated children with JDM. Symptoms lasting greater or equal to 2 months were associated with dendritic cell maturation and anti-angiogenic vascular remodelling, directly contributing to disease pathophysiology.


Parasite Immunology | 2015

Characterization of microRNA expression profiles in Leishmania-infected human phagocytes

Nicholas S. Geraci; John C. Tan; Mary Ann McDowell

Leishmania are intracellular protozoa that influence host immune responses eliciting parasite species‐specific pathologies. MicroRNAs (miRNAs) are short single‐stranded ribonucleic acids that complement gene transcripts to block protein translation and have been shown to regulate immune system molecular mechanisms. Human monocyte‐derived dendritic cells (DC) and macrophages (MP) were infected in vitro with Leishmania major or Leishmania donovani parasites. Small RNAs were isolated from total RNA and sequenced to identify mature miRNAs associated with leishmanial infections. Normalized sequence read count profiles revealed a global downregulation in miRNA expression among host cells following infection. Most identified miRNAs were expressed at higher levels in L. donovani‐infected cells relative to L. major‐infected cells. Pathway enrichments using in silico‐predicted gene targets of differentially expressed miRNAs showed evidence of potentially universal MAP kinase signalling pathway effects. Whereas JAK‐STAT and TGF‐β signalling pathways were more highly enriched using targets of miRNAs upregulated in L. donovani‐infected cells, these data provide evidence in support of a selective influence on host cell miRNA expression and regulation in response to differential Leishmania infections.


Journal of Immunology | 2014

Human Dendritic Cells Exhibit a Pronounced Type I IFN Signature following Leishmania major Infection That Is Required for IL-12 Induction

Michelle A. Favila; Nicholas S. Geraci; Erliang Zeng; Brent W. Harker; David Condon; Rachel N. Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell

Leishmania major–infected human dendritic cells (DCs) exhibit a marked induction of IL-12, ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. The host cell transcription machinery associated with the specific IL-12 induction observed during L. major infection remains to be thoroughly elucidated. In this study, we used Affymetrix GeneChip (Affymetrix) to globally assess the host cell genes and pathways associated with early L. major infection in human myeloid-derived DCs. Our data revealed 728 genes were significantly differentially expressed and molecular signaling pathway revealed that the type I IFN pathway was significantly enriched. Addition of a neutralizing type I IFN decoy receptor blocked the expression of IRF7 and IL-12p40 during DC infection, indicating the L. major–induced expression of IL-12p40 is dependent upon the type I IFN signaling pathway. In stark contrast, IL-12p40 expression is not elicited by L. donovani, the etiological agent of deadly visceral leishmaniasis. Therefore, we examined the gene expression profile for several IFN response genes in L. major versus L. donovani DC infections. Our data revealed that L. major, but not L. donovani, induces expression of IRF2, IRF7, and IFIT5, implicating the regulation of type I IFN–associated signaling pathways as mediating factors toward the production of IL-12.


Journal of Experimental Medicine | 2018

Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia

James C. Cronk; Anthony J. Filiano; Antoine Louveau; Ioana Marin; Rachel Marsh; Emily Ji; Dylan H. Goldman; Igor Smirnov; Nicholas S. Geraci; Scott T. Acton; Christopher C. Overall; Jonathan Kipnis

Peripherally derived macrophages infiltrate the brain after bone marrow transplantation and during central nervous system (CNS) inflammation. It was initially suggested that these engrafting cells were newly derived microglia and that irradiation was essential for engraftment to occur. However, it remains unclear whether brain-engrafting macrophages (beM&phgr;s) acquire a unique phenotype in the brain, whether long-term engraftment may occur without irradiation, and whether brain function is affected by the engrafted cells. In this study, we demonstrate that chronic, partial microglia depletion is sufficient for beM&phgr;s to populate the niche and that the presence of beM&phgr;s does not alter behavior. Furthermore, beM&phgr;s maintain a unique functional and transcriptional identity as compared with microglia. Overall, this study establishes beM&phgr;s as a unique CNS cell type and demonstrates that therapeutic engraftment of beM&phgr;s may be possible with irradiation-free conditioning regimens.


Parasite Immunology | 2012

Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells.

Michael J. Donovan; Vinita Tripathi; Michelle A. Favila; Nicholas S. Geraci; Marie C. Lange; Wibke Ballhorn; Mary Ann McDowell

Dendritic cells (DC) play a pivotal role in regulating immunity, establishing immunologically privileged tissue microenvironments and maintaining homoeostasis. It is becoming increasingly clear that one key mechanism that mediates many DC functions is production of the immunomodulatory enzyme indoleamine 2,3‐dioxygenase (IDO). For pathogens that cause chronic infection, exploitation of host DCs is a solution to establish and persist within a host. Leishmania parasites cause a range of clinical manifestations, all involving chronic infection, and are proficient at avoiding immune responses. We demonstrate here that infection of human myeloid‐derived DC with L. major and L. donovani induces IDO expression using a mechanism that involves autocrine or paracrine stimulation with a DC‐secreted factor. Leishmania‐induced IDO suppresses allogeneic and tetanus toxoid–specific lymphocyte proliferation, an inhibition that is reversed with the IDO inhibitor, 1‐methyl tryptophan (1‐MT). Furthermore, IDO expression by human DC does not require live Leishmania infection, as parasite lysates also up‐regulate IDO mRNA production. Our data suggest that one mechanism Leishmania parasites utilize to circumvent immune clearance may be to promote the induction of IDO among host DC within the infection microenvironment.


PLOS Neglected Tropical Diseases | 2015

Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells

Michelle A. Favila; Nicholas S. Geraci; Asha Jayakumar; Suzanne M. Hickerson; Janet Mostrom; Salvatore J. Turco; Stephen M. Beverley; Mary Ann McDowell

Background Leishmania major infection induces robust interleukin-12 (IL12) production in human dendritic cells (hDC), ultimately resulting in Th1-mediated immunity and clinical resolution. The surface of Leishmania parasites is covered in a dense glycocalyx consisting of primarily lipophosphoglycan (LPG) and other phosphoglycan-containing molecules (PGs), making these glycoconjugates the likely pathogen-associated molecular patterns (PAMPS) responsible for IL12 induction. Methodology/Principal Findings Here we explored the role of parasite glycoconjugates on the hDC IL12 response by generating L. major Friedlin V1 mutants defective in LPG alone, (FV1 lpg1-), or generally deficient for all PGs, (FV1 lpg2-). Infection with metacyclic, infective stage, L. major or purified LPG induced high levels of IL12B subunit gene transcripts in hDCs, which was abrogated with FV1 lpg1- infections. In contrast, hDC infections with FV1 lpg2- displayed increased IL12B expression, suggesting other PG-related/LPG2 dependent molecules may act to dampen the immune response. Global transcriptional profiling comparing WT, FV1 lpg1-, FV1 lpg2- infections revealed that FV1 lpg1- mutants entered hDCs in a silent fashion as indicated by repression of gene expression. Transcription factor binding site analysis suggests that LPG recognition by hDCs induces IL-12 in a signaling cascade resulting in Nuclear Factor κ B (NFκB) and Interferon Regulatory Factor (IRF) mediated transcription. Conclusions/Significance These data suggest that L. major LPG is a major PAMP recognized by hDC to induce IL12-mediated protective immunity and that there is a complex interplay between PG-baring Leishmania surface glycoconjugates that result in modulation of host cellular IL12.


American Journal of Tropical Medicine and Hygiene | 2014

Profiling of Human Acquired Immunity Against the Salivary Proteins of Phlebotomus papatasi Reveals Clusters of Differential Immunoreactivity

Nicholas S. Geraci; Rami M. Mukbel; Michael T. Kemp; Mariha Wadsworth; Emil Lesho; Gwen Stayback; Matthew M. Champion; Megan Bernard; Mahmoud N. Abo-Shehada; Iliano V. Coutinho-Abreu; Marcelo Ramalho-Ortigao; Hanafi A. Hanafi; Emadeldin Y. Fawaz; Shabaan S. El-Hossary; Glenn Wortmann; David F. Hoel; Mary Ann McDowell

Phlebotomus papatasi sand flies are among the primary vectors of Leishmania major parasites from Morocco to the Indian subcontinent and from southern Europe to central and eastern Africa. Antibody-based immunity to sand fly salivary gland proteins in human populations remains a complex contextual problem that is not yet fully understood. We profiled the immunoreactivities of plasma antibodies to sand fly salivary gland sonicates (SGSs) from 229 human blood donors residing in different regions of sand fly endemicity throughout Jordan and Egypt as well as 69 US military personnel, who were differentially exposed to P. papatasi bites and L. major infections in Iraq. Compared with plasma from control region donors, antibodies were significantly immunoreactive to five salivary proteins (12, 26, 30, 38, and 44 kDa) among Jordanian and Egyptian donors, with immunoglobulin G4 being the dominant anti-SGS isotype. US personnel were significantly immunoreactive to only two salivary proteins (38 and 14 kDa). Using k-means clustering, donors were segregated into four clusters distinguished by unique immunoreactivity profiles to varying combinations of the significantly immunogenic salivary proteins. SGS-induced cellular proliferation was diminished among donors residing in sand fly-endemic regions. These data provide a clearer picture of human immune responses to sand fly vector salivary constituents.


International Journal for Parasitology | 2007

Tick genomics: the Ixodes genome project and beyond.

J. Pagel Van Zee; Nicholas S. Geraci; Felix D. Guerrero; Stephen K. Wikel; Jeffrey J. Stuart; Vishvanath Nene; Catherine A. Hill


American Journal of Respiratory Cell and Molecular Biology | 2007

GM-CSF Regulates a PU.1-Dependent Transcriptional Program Determining the Pulmonary Response to LPS

Pierre-Yves Berclaz; Brenna Carey; Marie-Dominique Fillipi; Kara Wernke-Dollries; Nicholas S. Geraci; Stephanie Cush; Terry Richardson; Joe Kitzmiller; Michael O'Connor; Christina Hermoyian; Thomas R. Korfhagen; Jeffrey A. Whitsett; Bruce C. Trapnell


Insect Biochemistry and Molecular Biology | 2007

Variation in genome size of argasid and ixodid ticks

Nicholas S. Geraci; J. Spencer Johnston; J. Paul Robinson; Stephen K. Wikel; Catherine A. Hill

Collaboration


Dive into the Nicholas S. Geraci's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Asha Jayakumar

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Condon

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar

Erliang Zeng

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Felix D. Guerrero

Agricultural Research Service

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge